Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schold

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Cancer Research|August 1, 1988
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agentsH S Friedman, O M Colvin, S X Skapek, et al.
Journal of the National Cancer Institute|December 2, 1992
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastineD L Trump, D C Smith, P G Ellis, et al.
Neurology|March 1, 1988
Establishment of a CSF bankR E Albright, R H Christenson, S C Schold, et al.
Cancer Research|July 1, 1994
Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecanH S Friedman, M E Dolan, S H Kaufmann, et al.
Medical and Pediatric Oncology|January 1, 1991
Osteoblastic metastases from astrocytomas: a report of two casesD C Longee, H S Friedman, P C Phillips, et al.
Medical and Pediatric Oncology|January 1, 1991
Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem gliomaM Griebel, H S Friedman, E C Halperin, et al.
Annals of Neurology|March 1, 1991
Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancerF A Luque, H M Furneaux, R Ferziger, et al.
Seminars in Oncology|August 1, 1995
Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumorsD I Rosenthal, L G Close, J A Lucci, et al.
Cancer Research|August 11, 1991
Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MRE R Lilley, G B Elion, M W Dewhirst, et al.
Annals of Neurology|April 11, 1991
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomographyM J Glantz, J M Hoffman, R E Coleman, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Cancer Research|August 1, 1988
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agentsH S Friedman, O M Colvin, S X Skapek, et al.
Journal of the National Cancer Institute|December 2, 1992
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastineD L Trump, D C Smith, P G Ellis, et al.
Neurology|March 1, 1988
Establishment of a CSF bankR E Albright, R H Christenson, S C Schold, et al.
Cancer Research|July 1, 1994
Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecanH S Friedman, M E Dolan, S H Kaufmann, et al.
Medical and Pediatric Oncology|January 1, 1991
Osteoblastic metastases from astrocytomas: a report of two casesD C Longee, H S Friedman, P C Phillips, et al.
Medical and Pediatric Oncology|January 1, 1991
Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem gliomaM Griebel, H S Friedman, E C Halperin, et al.
Annals of Neurology|March 1, 1991
Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancerF A Luque, H M Furneaux, R Ferziger, et al.
Seminars in Oncology|August 1, 1995
Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumorsD I Rosenthal, L G Close, J A Lucci, et al.
Cancer Research|August 11, 1991
Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MRE R Lilley, G B Elion, M W Dewhirst, et al.
Annals of Neurology|April 11, 1991
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomographyM J Glantz, J M Hoffman, R E Coleman, et al.
Pageof 13